Free ACE inhibitors for diabetics could cut costs

	Tweet

In the US, Medicare could save money by covering the full cost of providing people with Diabetes with drugs called angiotensin-converting enzyme (ACE) inhibitors, according to new a research. ACE inhibitors prevent expensive complications, but patients’ out-of-pocket costs for the drugs pose a barrier, the investigators explain.

“There is a rare opportunity to save lives and money that should be quite appealing to policymakers,” said Dr. Allison B. Rosen from University of Michigan Health Systems. “It is a win-win situation: lives are saved, patients pay less, and Medicare pays less.”

Rosen and colleagues evaluated the cost-effectiveness to Medicare, the health coverage program for the elderly, of full coverage of ACE inhibitors for beneficiaries with diabetes.

Under current practice, Medicare incurs a total discounted lifetime cost of $117,549 per beneficiary with Diabetes, the report in the Annals of Internal Medicine indicates.

Were Medicare to pay the full cost of ACE inhibitor therapy, that cost would decrease to $115,943 while increasing life expectancy by 3 months, the team calculates.

The researchers note that these findings held good for a wide range of estimates of kidney and heart risks, costs and discount rates, and savings persisted after including implementation of the new Medicare drug benefit.

Rosen said that as the medical benefit of a drug goes up, it would “make sense” to reduce the amount that a patient has to co-pay for the drug. “In the future, we hope that payers would consider tailoring drug co-payments on a drug-by-drug and person-by-person basis,” she said.

SOURCE: Annals of Internal Medicine, July 19, 2005. 

RELATED STORIES:
Phone contact with nurses linked with better outcomes for women with gestational diabetes   Death rate drops among Americans with diabetes -CDC   Correct treatment of common diabetic foot infections can reduce amputations   “Pre-diabetes,” diabetes rising among U.S. teens   Experimental bariatric surgery controls blood sugar in rats with diabetes   53 millions Americans might develop diabetes by 2025   New inflammation hormone link may pave way to study new drugs for type 2 diabetes   Diabetic retinopathy research could reduce screening costs   Liver fat gets a wake-up call that maintains blood sugar levels   Low testosterone levels could raise diabetes risk for men   Prosthetic lets diabetic get a foot up on life   Dealing with Diabetes, One Patient at a Time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]